Federal Register of Legislation - Australian Government

Primary content

Other as made
This instrument declares that there is a serious scarcity across Australia of specified medicines containing the active ingredient abatacept, and specifies the substitutable medicines that pharmacists are permitted to dispense in substitution in permitted circumstances.
Administered by: Health
Registered 08 Feb 2022
Tabling HistoryDate
Tabled HR09-Feb-2022
Tabled Senate10-Feb-2022
Date ceased to have effect 30 Jun 2022
Ceased by Self Ceasing
Enabled by
Authoritative version Therapeutic Goods Act 1989
C2004A03952No. 21, 1990